nodes	percent_of_prediction	percent_of_DWPC	metapath
Morphine—ABCB1—colon cancer	0.417	1	CbGaD
Morphine—UGT1A1—Irinotecan—colon cancer	0.144	0.505	CbGbCtD
Morphine—CYP2C8—Fluorouracil—colon cancer	0.0404	0.142	CbGbCtD
Morphine—ABCB1—Irinotecan—colon cancer	0.0285	0.1	CbGbCtD
Morphine—ABCB1—Vincristine—colon cancer	0.0249	0.0875	CbGbCtD
Morphine—CYP3A4—Irinotecan—colon cancer	0.0171	0.06	CbGbCtD
Morphine—ABCB1—Methotrexate—colon cancer	0.0151	0.053	CbGbCtD
Morphine—CYP3A4—Vincristine—colon cancer	0.0149	0.0524	CbGbCtD
Morphine—UGT2B15—gall bladder—colon cancer	0.00699	0.13	CbGeAlD
Morphine—UGT1A8—renal system—colon cancer	0.004	0.0746	CbGeAlD
Morphine—UGT1A8—digestive system—colon cancer	0.00328	0.0611	CbGeAlD
Morphine—OPRL1—lymphoid tissue—colon cancer	0.00324	0.0603	CbGeAlD
Morphine—UGT1A3—digestive system—colon cancer	0.00293	0.0545	CbGeAlD
Morphine—UGT2B15—digestive system—colon cancer	0.00275	0.0512	CbGeAlD
Morphine—UGT1A8—liver—colon cancer	0.00245	0.0456	CbGeAlD
Morphine—UGT2B4—liver—colon cancer	0.00228	0.0424	CbGeAlD
Morphine—UGT1A3—liver—colon cancer	0.00218	0.0406	CbGeAlD
Morphine—UGT2B15—liver—colon cancer	0.00205	0.0382	CbGeAlD
Morphine—UGT2B7—renal system—colon cancer	0.00205	0.0382	CbGeAlD
Morphine—OPRD1—renal system—colon cancer	0.00201	0.0374	CbGeAlD
Morphine—OPRL1—lymph node—colon cancer	0.00183	0.034	CbGeAlD
Morphine—UGT1A1—renal system—colon cancer	0.00174	0.0325	CbGeAlD
Morphine—UGT2B7—digestive system—colon cancer	0.00168	0.0313	CbGeAlD
Morphine—UGT1A1—digestive system—colon cancer	0.00143	0.0266	CbGeAlD
Morphine—UGT2B7—liver—colon cancer	0.00125	0.0233	CbGeAlD
Morphine—UGT1A1—liver—colon cancer	0.00107	0.0198	CbGeAlD
Morphine—ABCB1—blood vessel—colon cancer	0.000876	0.0163	CbGeAlD
Morphine—CYP2C8—renal system—colon cancer	0.000825	0.0154	CbGeAlD
Morphine—CYP2C8—vagina—colon cancer	0.000597	0.0111	CbGeAlD
Morphine—CYP3A4—renal system—colon cancer	0.000559	0.0104	CbGeAlD
Morphine—CYP2D6—renal system—colon cancer	0.00055	0.0102	CbGeAlD
Morphine—ABCB1—embryo—colon cancer	0.000522	0.00973	CbGeAlD
Morphine—CYP2C8—liver—colon cancer	0.000504	0.00938	CbGeAlD
Morphine—CYP3A4—digestive system—colon cancer	0.000458	0.00853	CbGeAlD
Morphine—CYP2D6—digestive system—colon cancer	0.000451	0.00839	CbGeAlD
Morphine—ABCB1—epithelium—colon cancer	0.000426	0.00794	CbGeAlD
Morphine—ABCB1—renal system—colon cancer	0.000395	0.00736	CbGeAlD
Morphine—CYP3A4—liver—colon cancer	0.000341	0.00635	CbGeAlD
Morphine—CYP2D6—liver—colon cancer	0.000336	0.00625	CbGeAlD
Morphine—ABCB1—lymphoid tissue—colon cancer	0.000328	0.00611	CbGeAlD
Morphine—ABCB1—digestive system—colon cancer	0.000324	0.00604	CbGeAlD
Morphine—Anaphylactoid reaction—Methotrexate—colon cancer	0.000313	0.00139	CcSEcCtD
Morphine—Lethargy—Methotrexate—colon cancer	0.000309	0.00138	CcSEcCtD
Morphine—Renal failure—Capecitabine—colon cancer	0.000308	0.00137	CcSEcCtD
Morphine—Discomfort—Irinotecan—colon cancer	0.000308	0.00137	CcSEcCtD
Morphine—Anaphylactic shock—Vincristine—colon cancer	0.000306	0.00137	CcSEcCtD
Morphine—Oedema—Vincristine—colon cancer	0.000306	0.00137	CcSEcCtD
Morphine—Stomatitis—Capecitabine—colon cancer	0.000305	0.00136	CcSEcCtD
Morphine—Infection—Vincristine—colon cancer	0.000304	0.00136	CcSEcCtD
Morphine—Urinary tract infection—Capecitabine—colon cancer	0.000304	0.00136	CcSEcCtD
Morphine—Conjunctivitis—Capecitabine—colon cancer	0.000304	0.00136	CcSEcCtD
Morphine—Convulsion—Fluorouracil—colon cancer	0.000303	0.00135	CcSEcCtD
Morphine—Osteoarthritis—Methotrexate—colon cancer	0.000302	0.00135	CcSEcCtD
Morphine—Confusional state—Irinotecan—colon cancer	0.000301	0.00134	CcSEcCtD
Morphine—Nervous system disorder—Vincristine—colon cancer	0.0003	0.00134	CcSEcCtD
Morphine—Thrombocytopenia—Vincristine—colon cancer	0.0003	0.00134	CcSEcCtD
Morphine—ABCB1—bone marrow—colon cancer	0.000299	0.00557	CbGeAlD
Morphine—Oedema—Irinotecan—colon cancer	0.000298	0.00133	CcSEcCtD
Morphine—Anaphylactic shock—Irinotecan—colon cancer	0.000298	0.00133	CcSEcCtD
Morphine—Chest pain—Fluorouracil—colon cancer	0.000298	0.00133	CcSEcCtD
Morphine—Infection—Irinotecan—colon cancer	0.000296	0.00132	CcSEcCtD
Morphine—Hyperhidrosis—Vincristine—colon cancer	0.000296	0.00132	CcSEcCtD
Morphine—Hepatobiliary disease—Capecitabine—colon cancer	0.000296	0.00132	CcSEcCtD
Morphine—Discomfort—Fluorouracil—colon cancer	0.000295	0.00131	CcSEcCtD
Morphine—Shock—Irinotecan—colon cancer	0.000294	0.00131	CcSEcCtD
Morphine—Nervous system disorder—Irinotecan—colon cancer	0.000293	0.00131	CcSEcCtD
Morphine—Thrombocytopenia—Irinotecan—colon cancer	0.000292	0.0013	CcSEcCtD
Morphine—Anorexia—Vincristine—colon cancer	0.000292	0.0013	CcSEcCtD
Morphine—Hyperhidrosis—Irinotecan—colon cancer	0.000288	0.00129	CcSEcCtD
Morphine—Confusional state—Fluorouracil—colon cancer	0.000288	0.00129	CcSEcCtD
Morphine—Mood swings—Methotrexate—colon cancer	0.000287	0.00128	CcSEcCtD
Morphine—ABCB1—vagina—colon cancer	0.000286	0.00533	CbGeAlD
Morphine—Hypotension—Vincristine—colon cancer	0.000286	0.00128	CcSEcCtD
Morphine—Bradycardia—Capecitabine—colon cancer	0.000286	0.00128	CcSEcCtD
Morphine—Anaphylactic shock—Fluorouracil—colon cancer	0.000286	0.00127	CcSEcCtD
Morphine—Oedema—Fluorouracil—colon cancer	0.000286	0.00127	CcSEcCtD
Morphine—Anorexia—Irinotecan—colon cancer	0.000284	0.00127	CcSEcCtD
Morphine—Ataxia—Methotrexate—colon cancer	0.000284	0.00127	CcSEcCtD
Morphine—Infection—Fluorouracil—colon cancer	0.000284	0.00127	CcSEcCtD
Morphine—Rhinitis—Capecitabine—colon cancer	0.000282	0.00126	CcSEcCtD
Morphine—Hepatitis—Capecitabine—colon cancer	0.000281	0.00125	CcSEcCtD
Morphine—Nervous system disorder—Fluorouracil—colon cancer	0.00028	0.00125	CcSEcCtD
Morphine—Thrombocytopenia—Fluorouracil—colon cancer	0.00028	0.00125	CcSEcCtD
Morphine—Hypoaesthesia—Capecitabine—colon cancer	0.00028	0.00125	CcSEcCtD
Morphine—Liver function test abnormal—Methotrexate—colon cancer	0.000279	0.00125	CcSEcCtD
Morphine—Musculoskeletal discomfort—Vincristine—colon cancer	0.000279	0.00125	CcSEcCtD
Morphine—Tachycardia—Fluorouracil—colon cancer	0.000279	0.00124	CcSEcCtD
Morphine—Hypotension—Irinotecan—colon cancer	0.000279	0.00124	CcSEcCtD
Morphine—Urinary tract disorder—Capecitabine—colon cancer	0.000278	0.00124	CcSEcCtD
Morphine—Insomnia—Vincristine—colon cancer	0.000277	0.00124	CcSEcCtD
Morphine—Oedema peripheral—Capecitabine—colon cancer	0.000277	0.00124	CcSEcCtD
Morphine—Connective tissue disorder—Capecitabine—colon cancer	0.000276	0.00123	CcSEcCtD
Morphine—Urethral disorder—Capecitabine—colon cancer	0.000276	0.00123	CcSEcCtD
Morphine—Paraesthesia—Vincristine—colon cancer	0.000275	0.00123	CcSEcCtD
Morphine—Breast disorder—Methotrexate—colon cancer	0.000273	0.00122	CcSEcCtD
Morphine—Anorexia—Fluorouracil—colon cancer	0.000272	0.00122	CcSEcCtD
Morphine—Visual impairment—Capecitabine—colon cancer	0.000271	0.00121	CcSEcCtD
Morphine—Insomnia—Irinotecan—colon cancer	0.00027	0.0012	CcSEcCtD
Morphine—Paraesthesia—Irinotecan—colon cancer	0.000268	0.0012	CcSEcCtD
Morphine—Hypotension—Fluorouracil—colon cancer	0.000267	0.00119	CcSEcCtD
Morphine—Decreased appetite—Vincristine—colon cancer	0.000266	0.00119	CcSEcCtD
Morphine—Dyspnoea—Irinotecan—colon cancer	0.000266	0.00119	CcSEcCtD
Morphine—Somnolence—Irinotecan—colon cancer	0.000265	0.00118	CcSEcCtD
Morphine—Gastrointestinal disorder—Vincristine—colon cancer	0.000265	0.00118	CcSEcCtD
Morphine—Fatigue—Vincristine—colon cancer	0.000264	0.00118	CcSEcCtD
Morphine—Eye disorder—Capecitabine—colon cancer	0.000263	0.00117	CcSEcCtD
Morphine—Dyspepsia—Irinotecan—colon cancer	0.000263	0.00117	CcSEcCtD
Morphine—Pain—Vincristine—colon cancer	0.000262	0.00117	CcSEcCtD
Morphine—Constipation—Vincristine—colon cancer	0.000262	0.00117	CcSEcCtD
Morphine—Flushing—Capecitabine—colon cancer	0.000261	0.00116	CcSEcCtD
Morphine—Musculoskeletal discomfort—Fluorouracil—colon cancer	0.00026	0.00116	CcSEcCtD
Morphine—Decreased appetite—Irinotecan—colon cancer	0.000259	0.00116	CcSEcCtD
Morphine—Eosinophilia—Methotrexate—colon cancer	0.000259	0.00115	CcSEcCtD
Morphine—Insomnia—Fluorouracil—colon cancer	0.000258	0.00115	CcSEcCtD
Morphine—Gastrointestinal disorder—Irinotecan—colon cancer	0.000258	0.00115	CcSEcCtD
Morphine—Fatigue—Irinotecan—colon cancer	0.000257	0.00115	CcSEcCtD
Morphine—Paraesthesia—Fluorouracil—colon cancer	0.000257	0.00114	CcSEcCtD
Morphine—Pain—Irinotecan—colon cancer	0.000255	0.00114	CcSEcCtD
Morphine—Constipation—Irinotecan—colon cancer	0.000255	0.00114	CcSEcCtD
Morphine—Angiopathy—Capecitabine—colon cancer	0.000255	0.00114	CcSEcCtD
Morphine—Dyspnoea—Fluorouracil—colon cancer	0.000255	0.00114	CcSEcCtD
Morphine—Somnolence—Fluorouracil—colon cancer	0.000254	0.00113	CcSEcCtD
Morphine—Mediastinal disorder—Capecitabine—colon cancer	0.000253	0.00113	CcSEcCtD
Morphine—Chills—Capecitabine—colon cancer	0.000252	0.00112	CcSEcCtD
Morphine—Dyspepsia—Fluorouracil—colon cancer	0.000252	0.00112	CcSEcCtD
Morphine—Gastrointestinal pain—Vincristine—colon cancer	0.000251	0.00112	CcSEcCtD
Morphine—Decreased appetite—Fluorouracil—colon cancer	0.000248	0.00111	CcSEcCtD
Morphine—Gastrointestinal disorder—Fluorouracil—colon cancer	0.000247	0.0011	CcSEcCtD
Morphine—Mental disorder—Capecitabine—colon cancer	0.000246	0.0011	CcSEcCtD
Morphine—Feeling abnormal—Irinotecan—colon cancer	0.000246	0.0011	CcSEcCtD
Morphine—Erythema—Capecitabine—colon cancer	0.000245	0.00109	CcSEcCtD
Morphine—Malnutrition—Capecitabine—colon cancer	0.000245	0.00109	CcSEcCtD
Morphine—Dysuria—Methotrexate—colon cancer	0.000244	0.00109	CcSEcCtD
Morphine—Pain—Fluorouracil—colon cancer	0.000244	0.00109	CcSEcCtD
Morphine—Gastrointestinal pain—Irinotecan—colon cancer	0.000244	0.00109	CcSEcCtD
Morphine—Abdominal pain—Vincristine—colon cancer	0.000242	0.00108	CcSEcCtD
Morphine—Body temperature increased—Vincristine—colon cancer	0.000242	0.00108	CcSEcCtD
Morphine—ABCB1—liver—colon cancer	0.000242	0.0045	CbGeAlD
Morphine—Flatulence—Capecitabine—colon cancer	0.000241	0.00108	CcSEcCtD
Morphine—Erectile dysfunction—Methotrexate—colon cancer	0.000241	0.00107	CcSEcCtD
Morphine—Dysgeusia—Capecitabine—colon cancer	0.00024	0.00107	CcSEcCtD
Morphine—Back pain—Capecitabine—colon cancer	0.000237	0.00106	CcSEcCtD
Morphine—Body temperature increased—Irinotecan—colon cancer	0.000236	0.00105	CcSEcCtD
Morphine—Abdominal pain—Irinotecan—colon cancer	0.000236	0.00105	CcSEcCtD
Morphine—Feeling abnormal—Fluorouracil—colon cancer	0.000235	0.00105	CcSEcCtD
Morphine—Muscle spasms—Capecitabine—colon cancer	0.000235	0.00105	CcSEcCtD
Morphine—Drowsiness—Methotrexate—colon cancer	0.000233	0.00104	CcSEcCtD
Morphine—Vision blurred—Capecitabine—colon cancer	0.000231	0.00103	CcSEcCtD
Morphine—Tremor—Capecitabine—colon cancer	0.000229	0.00102	CcSEcCtD
Morphine—Renal failure—Methotrexate—colon cancer	0.000229	0.00102	CcSEcCtD
Morphine—Stomatitis—Methotrexate—colon cancer	0.000227	0.00101	CcSEcCtD
Morphine—Ill-defined disorder—Capecitabine—colon cancer	0.000227	0.00101	CcSEcCtD
Morphine—Urticaria—Fluorouracil—colon cancer	0.000227	0.00101	CcSEcCtD
Morphine—Conjunctivitis—Methotrexate—colon cancer	0.000227	0.00101	CcSEcCtD
Morphine—Anaemia—Capecitabine—colon cancer	0.000226	0.00101	CcSEcCtD
Morphine—Body temperature increased—Fluorouracil—colon cancer	0.000226	0.00101	CcSEcCtD
Morphine—Hypersensitivity—Vincristine—colon cancer	0.000226	0.00101	CcSEcCtD
Morphine—Sweating—Methotrexate—colon cancer	0.000223	0.000997	CcSEcCtD
Morphine—Malaise—Capecitabine—colon cancer	0.000221	0.000984	CcSEcCtD
Morphine—Hepatobiliary disease—Methotrexate—colon cancer	0.00022	0.000983	CcSEcCtD
Morphine—Vertigo—Capecitabine—colon cancer	0.00022	0.000981	CcSEcCtD
Morphine—Hypersensitivity—Irinotecan—colon cancer	0.00022	0.000981	CcSEcCtD
Morphine—Asthenia—Vincristine—colon cancer	0.00022	0.00098	CcSEcCtD
Morphine—Syncope—Capecitabine—colon cancer	0.000219	0.000979	CcSEcCtD
Morphine—Leukopenia—Capecitabine—colon cancer	0.000219	0.000977	CcSEcCtD
Morphine—Palpitations—Capecitabine—colon cancer	0.000216	0.000964	CcSEcCtD
Morphine—Loss of consciousness—Capecitabine—colon cancer	0.000215	0.000959	CcSEcCtD
Morphine—Asthenia—Irinotecan—colon cancer	0.000214	0.000955	CcSEcCtD
Morphine—Cough—Capecitabine—colon cancer	0.000214	0.000952	CcSEcCtD
Morphine—Hypertension—Capecitabine—colon cancer	0.000211	0.000942	CcSEcCtD
Morphine—Hypersensitivity—Fluorouracil—colon cancer	0.000211	0.000939	CcSEcCtD
Morphine—Diarrhoea—Vincristine—colon cancer	0.00021	0.000935	CcSEcCtD
Morphine—Hepatitis—Methotrexate—colon cancer	0.000209	0.000933	CcSEcCtD
Morphine—Arthralgia—Capecitabine—colon cancer	0.000208	0.000929	CcSEcCtD
Morphine—Chest pain—Capecitabine—colon cancer	0.000208	0.000929	CcSEcCtD
Morphine—Anxiety—Capecitabine—colon cancer	0.000208	0.000926	CcSEcCtD
Morphine—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—colon cancer	0.000207	0.000923	CcSEcCtD
Morphine—Urinary tract disorder—Methotrexate—colon cancer	0.000207	0.000922	CcSEcCtD
Morphine—Discomfort—Capecitabine—colon cancer	0.000206	0.000918	CcSEcCtD
Morphine—Urethral disorder—Methotrexate—colon cancer	0.000205	0.000915	CcSEcCtD
Morphine—Diarrhoea—Irinotecan—colon cancer	0.000204	0.000911	CcSEcCtD
Morphine—Dry mouth—Capecitabine—colon cancer	0.000204	0.000909	CcSEcCtD
Morphine—Dizziness—Vincristine—colon cancer	0.000203	0.000904	CcSEcCtD
Morphine—Pruritus—Fluorouracil—colon cancer	0.000202	0.000902	CcSEcCtD
Morphine—Visual impairment—Methotrexate—colon cancer	0.000202	0.000899	CcSEcCtD
Morphine—Confusional state—Capecitabine—colon cancer	0.000201	0.000898	CcSEcCtD
Morphine—Oedema—Capecitabine—colon cancer	0.0002	0.000891	CcSEcCtD
Morphine—Infection—Capecitabine—colon cancer	0.000198	0.000885	CcSEcCtD
Morphine—Dizziness—Irinotecan—colon cancer	0.000197	0.00088	CcSEcCtD
Morphine—Shock—Capecitabine—colon cancer	0.000196	0.000876	CcSEcCtD
Morphine—Nervous system disorder—Capecitabine—colon cancer	0.000196	0.000874	CcSEcCtD
Morphine—Eye disorder—Methotrexate—colon cancer	0.000196	0.000872	CcSEcCtD
Morphine—Diarrhoea—Fluorouracil—colon cancer	0.000196	0.000872	CcSEcCtD
Morphine—Thrombocytopenia—Capecitabine—colon cancer	0.000196	0.000872	CcSEcCtD
Morphine—Tachycardia—Capecitabine—colon cancer	0.000195	0.000869	CcSEcCtD
Morphine—Vomiting—Vincristine—colon cancer	0.000195	0.000869	CcSEcCtD
Morphine—Skin disorder—Capecitabine—colon cancer	0.000194	0.000865	CcSEcCtD
Morphine—Rash—Vincristine—colon cancer	0.000193	0.000862	CcSEcCtD
Morphine—Hyperhidrosis—Capecitabine—colon cancer	0.000193	0.000861	CcSEcCtD
Morphine—Dermatitis—Vincristine—colon cancer	0.000193	0.000861	CcSEcCtD
Morphine—Headache—Vincristine—colon cancer	0.000192	0.000856	CcSEcCtD
Morphine—Anorexia—Capecitabine—colon cancer	0.00019	0.000849	CcSEcCtD
Morphine—Angiopathy—Methotrexate—colon cancer	0.00019	0.000847	CcSEcCtD
Morphine—Vomiting—Irinotecan—colon cancer	0.00019	0.000846	CcSEcCtD
Morphine—Dizziness—Fluorouracil—colon cancer	0.000189	0.000843	CcSEcCtD
Morphine—Mediastinal disorder—Methotrexate—colon cancer	0.000189	0.000841	CcSEcCtD
Morphine—Rash—Irinotecan—colon cancer	0.000188	0.000839	CcSEcCtD
Morphine—Dermatitis—Irinotecan—colon cancer	0.000188	0.000838	CcSEcCtD
Morphine—Chills—Methotrexate—colon cancer	0.000188	0.000837	CcSEcCtD
Morphine—Headache—Irinotecan—colon cancer	0.000187	0.000834	CcSEcCtD
Morphine—Hypotension—Capecitabine—colon cancer	0.000187	0.000832	CcSEcCtD
Morphine—ABCB1—lymph node—colon cancer	0.000185	0.00345	CbGeAlD
Morphine—Mental disorder—Methotrexate—colon cancer	0.000183	0.000818	CcSEcCtD
Morphine—Malnutrition—Methotrexate—colon cancer	0.000182	0.000812	CcSEcCtD
Morphine—Erythema—Methotrexate—colon cancer	0.000182	0.000812	CcSEcCtD
Morphine—Nausea—Vincristine—colon cancer	0.000182	0.000812	CcSEcCtD
Morphine—Musculoskeletal discomfort—Capecitabine—colon cancer	0.000182	0.000812	CcSEcCtD
Morphine—Vomiting—Fluorouracil—colon cancer	0.000182	0.00081	CcSEcCtD
Morphine—Naltrexone—ABCB1—colon cancer	0.000181	0.578	CrCbGaD
Morphine—Insomnia—Capecitabine—colon cancer	0.000181	0.000806	CcSEcCtD
Morphine—Rash—Fluorouracil—colon cancer	0.00018	0.000804	CcSEcCtD
Morphine—Dermatitis—Fluorouracil—colon cancer	0.00018	0.000803	CcSEcCtD
Morphine—Paraesthesia—Capecitabine—colon cancer	0.000179	0.0008	CcSEcCtD
Morphine—Headache—Fluorouracil—colon cancer	0.000179	0.000799	CcSEcCtD
Morphine—Dysgeusia—Methotrexate—colon cancer	0.000178	0.000796	CcSEcCtD
Morphine—Dyspnoea—Capecitabine—colon cancer	0.000178	0.000794	CcSEcCtD
Morphine—Nausea—Irinotecan—colon cancer	0.000177	0.000791	CcSEcCtD
Morphine—Back pain—Methotrexate—colon cancer	0.000176	0.000786	CcSEcCtD
Morphine—Dyspepsia—Capecitabine—colon cancer	0.000176	0.000784	CcSEcCtD
Morphine—Decreased appetite—Capecitabine—colon cancer	0.000174	0.000774	CcSEcCtD
Morphine—Gastrointestinal disorder—Capecitabine—colon cancer	0.000172	0.000769	CcSEcCtD
Morphine—Fatigue—Capecitabine—colon cancer	0.000172	0.000768	CcSEcCtD
Morphine—Vision blurred—Methotrexate—colon cancer	0.000172	0.000766	CcSEcCtD
Morphine—Constipation—Capecitabine—colon cancer	0.000171	0.000762	CcSEcCtD
Morphine—Pain—Capecitabine—colon cancer	0.000171	0.000762	CcSEcCtD
Morphine—Nausea—Fluorouracil—colon cancer	0.00017	0.000757	CcSEcCtD
Morphine—Ill-defined disorder—Methotrexate—colon cancer	0.000169	0.000754	CcSEcCtD
Morphine—Anaemia—Methotrexate—colon cancer	0.000168	0.000751	CcSEcCtD
Morphine—Feeling abnormal—Capecitabine—colon cancer	0.000165	0.000734	CcSEcCtD
Morphine—Malaise—Methotrexate—colon cancer	0.000164	0.000733	CcSEcCtD
Morphine—Vertigo—Methotrexate—colon cancer	0.000164	0.00073	CcSEcCtD
Morphine—Gastrointestinal pain—Capecitabine—colon cancer	0.000163	0.000728	CcSEcCtD
Morphine—Leukopenia—Methotrexate—colon cancer	0.000163	0.000727	CcSEcCtD
Morphine—Cough—Methotrexate—colon cancer	0.000159	0.000709	CcSEcCtD
Morphine—Urticaria—Capecitabine—colon cancer	0.000159	0.000708	CcSEcCtD
Morphine—Abdominal pain—Capecitabine—colon cancer	0.000158	0.000704	CcSEcCtD
Morphine—Body temperature increased—Capecitabine—colon cancer	0.000158	0.000704	CcSEcCtD
Morphine—Convulsion—Methotrexate—colon cancer	0.000158	0.000704	CcSEcCtD
Morphine—Chest pain—Methotrexate—colon cancer	0.000155	0.000692	CcSEcCtD
Morphine—Arthralgia—Methotrexate—colon cancer	0.000155	0.000692	CcSEcCtD
Morphine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—colon cancer	0.000154	0.000687	CcSEcCtD
Morphine—Discomfort—Methotrexate—colon cancer	0.000153	0.000683	CcSEcCtD
Morphine—Confusional state—Methotrexate—colon cancer	0.00015	0.000669	CcSEcCtD
Morphine—Anaphylactic shock—Methotrexate—colon cancer	0.000149	0.000663	CcSEcCtD
Morphine—Infection—Methotrexate—colon cancer	0.000148	0.000659	CcSEcCtD
Morphine—Hypersensitivity—Capecitabine—colon cancer	0.000147	0.000656	CcSEcCtD
Morphine—Nervous system disorder—Methotrexate—colon cancer	0.000146	0.00065	CcSEcCtD
Morphine—Thrombocytopenia—Methotrexate—colon cancer	0.000146	0.000649	CcSEcCtD
Morphine—Skin disorder—Methotrexate—colon cancer	0.000144	0.000644	CcSEcCtD
Morphine—Hyperhidrosis—Methotrexate—colon cancer	0.000144	0.000641	CcSEcCtD
Morphine—Asthenia—Capecitabine—colon cancer	0.000143	0.000639	CcSEcCtD
Morphine—Anorexia—Methotrexate—colon cancer	0.000142	0.000632	CcSEcCtD
Morphine—Pruritus—Capecitabine—colon cancer	0.000141	0.00063	CcSEcCtD
Morphine—Hypotension—Methotrexate—colon cancer	0.000139	0.00062	CcSEcCtD
Morphine—Diarrhoea—Capecitabine—colon cancer	0.000137	0.000609	CcSEcCtD
Morphine—Musculoskeletal discomfort—Methotrexate—colon cancer	0.000135	0.000604	CcSEcCtD
Morphine—Insomnia—Methotrexate—colon cancer	0.000134	0.0006	CcSEcCtD
Morphine—Paraesthesia—Methotrexate—colon cancer	0.000133	0.000595	CcSEcCtD
Morphine—Dyspnoea—Methotrexate—colon cancer	0.000133	0.000591	CcSEcCtD
Morphine—Naloxone—ABCB1—colon cancer	0.000132	0.422	CrCbGaD
Morphine—Somnolence—Methotrexate—colon cancer	0.000132	0.000589	CcSEcCtD
Morphine—Dizziness—Capecitabine—colon cancer	0.000132	0.000589	CcSEcCtD
Morphine—Dyspepsia—Methotrexate—colon cancer	0.000131	0.000584	CcSEcCtD
Morphine—Decreased appetite—Methotrexate—colon cancer	0.000129	0.000576	CcSEcCtD
Morphine—Gastrointestinal disorder—Methotrexate—colon cancer	0.000128	0.000572	CcSEcCtD
Morphine—Fatigue—Methotrexate—colon cancer	0.000128	0.000572	CcSEcCtD
Morphine—Pain—Methotrexate—colon cancer	0.000127	0.000567	CcSEcCtD
Morphine—Vomiting—Capecitabine—colon cancer	0.000127	0.000566	CcSEcCtD
Morphine—Rash—Capecitabine—colon cancer	0.000126	0.000562	CcSEcCtD
Morphine—Dermatitis—Capecitabine—colon cancer	0.000126	0.000561	CcSEcCtD
Morphine—Headache—Capecitabine—colon cancer	0.000125	0.000558	CcSEcCtD
Morphine—Feeling abnormal—Methotrexate—colon cancer	0.000123	0.000546	CcSEcCtD
Morphine—Gastrointestinal pain—Methotrexate—colon cancer	0.000122	0.000542	CcSEcCtD
Morphine—Nausea—Capecitabine—colon cancer	0.000119	0.000529	CcSEcCtD
Morphine—Urticaria—Methotrexate—colon cancer	0.000118	0.000527	CcSEcCtD
Morphine—Abdominal pain—Methotrexate—colon cancer	0.000118	0.000524	CcSEcCtD
Morphine—Body temperature increased—Methotrexate—colon cancer	0.000118	0.000524	CcSEcCtD
Morphine—Hypersensitivity—Methotrexate—colon cancer	0.00011	0.000489	CcSEcCtD
Morphine—Asthenia—Methotrexate—colon cancer	0.000107	0.000476	CcSEcCtD
Morphine—Pruritus—Methotrexate—colon cancer	0.000105	0.000469	CcSEcCtD
Morphine—Diarrhoea—Methotrexate—colon cancer	0.000102	0.000454	CcSEcCtD
Morphine—Dizziness—Methotrexate—colon cancer	9.83e-05	0.000438	CcSEcCtD
Morphine—Vomiting—Methotrexate—colon cancer	9.45e-05	0.000422	CcSEcCtD
Morphine—Rash—Methotrexate—colon cancer	9.37e-05	0.000418	CcSEcCtD
Morphine—Dermatitis—Methotrexate—colon cancer	9.36e-05	0.000418	CcSEcCtD
Morphine—Headache—Methotrexate—colon cancer	9.31e-05	0.000415	CcSEcCtD
Morphine—Nausea—Methotrexate—colon cancer	8.83e-05	0.000394	CcSEcCtD
Morphine—UGT1A1—Metabolism—CA7—colon cancer	8.03e-05	0.00398	CbGpPWpGaD
Morphine—CYP3A4—Metapathway biotransformation—CHST5—colon cancer	7.93e-05	0.00393	CbGpPWpGaD
Morphine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—colon cancer	7.77e-05	0.00385	CbGpPWpGaD
Morphine—UGT1A3—Metabolism—ODC1—colon cancer	7.04e-05	0.00349	CbGpPWpGaD
Morphine—UGT1A3—Metabolism—CHST5—colon cancer	7.04e-05	0.00349	CbGpPWpGaD
Morphine—OPRL1—Circadian rythm related genes—TP53—colon cancer	6.68e-05	0.00331	CbGpPWpGaD
Morphine—ABCB1—Integrated Pancreatic Cancer Pathway—DCC—colon cancer	6.04e-05	0.00299	CbGpPWpGaD
Morphine—UGT2B7—Metabolism—CHST5—colon cancer	5.99e-05	0.00297	CbGpPWpGaD
Morphine—UGT2B7—Metabolism—ODC1—colon cancer	5.99e-05	0.00297	CbGpPWpGaD
Morphine—CYP2C8—Arachidonic acid metabolism—PTGS2—colon cancer	5.82e-05	0.00289	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—DLC1—colon cancer	5.71e-05	0.00283	CbGpPWpGaD
Morphine—OPRM1—IL4-mediated signaling events—PIK3CA—colon cancer	5.6e-05	0.00278	CbGpPWpGaD
Morphine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—colon cancer	5.41e-05	0.00268	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—LGR5—colon cancer	5.37e-05	0.00266	CbGpPWpGaD
Morphine—ABCB1—Integrated Pancreatic Cancer Pathway—HNF4A—colon cancer	5.08e-05	0.00252	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—DLC1—colon cancer	5.01e-05	0.00248	CbGpPWpGaD
Morphine—UGT1A3—NRF2 pathway—TGFB1—colon cancer	4.91e-05	0.00243	CbGpPWpGaD
Morphine—OPRM1—TCR Signaling Pathway—TGFB1—colon cancer	4.88e-05	0.00242	CbGpPWpGaD
Morphine—UGT1A1—Metabolism—ODC1—colon cancer	4.86e-05	0.00241	CbGpPWpGaD
Morphine—UGT1A1—Metabolism—CHST5—colon cancer	4.86e-05	0.00241	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—LGR5—colon cancer	4.71e-05	0.00233	CbGpPWpGaD
Morphine—OPRM1—IL4-mediated signaling events—AKT1—colon cancer	4.57e-05	0.00227	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—DLC1—colon cancer	4.23e-05	0.0021	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—CA7—colon cancer	4.23e-05	0.0021	CbGpPWpGaD
Morphine—UGT2B7—NRF2 pathway—TGFB1—colon cancer	4.17e-05	0.00207	CbGpPWpGaD
Morphine—ABCB1—Integrated Pancreatic Cancer Pathway—BUB1B—colon cancer	4.06e-05	0.00201	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—LGR5—colon cancer	3.98e-05	0.00197	CbGpPWpGaD
Morphine—UGT1A8—Metabolism—ABCB1—colon cancer	3.97e-05	0.00197	CbGpPWpGaD
Morphine—UGT1A8—Metabolism—TYMS—colon cancer	3.9e-05	0.00194	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—AXIN2—colon cancer	3.86e-05	0.00191	CbGpPWpGaD
Morphine—OPRM1—TCR Signaling Pathway—HRAS—colon cancer	3.84e-05	0.00191	CbGpPWpGaD
Morphine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—colon cancer	3.73e-05	0.00185	CbGpPWpGaD
Morphine—ABCB1—Metabolism—CA7—colon cancer	3.68e-05	0.00183	CbGpPWpGaD
Morphine—UGT2B15—Metabolism—ABCB1—colon cancer	3.47e-05	0.00172	CbGpPWpGaD
Morphine—UGT2B4—Metabolism—ABCB1—colon cancer	3.47e-05	0.00172	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—CA7—colon cancer	3.47e-05	0.00172	CbGpPWpGaD
Morphine—UGT2B15—Metabolism—TYMS—colon cancer	3.41e-05	0.00169	CbGpPWpGaD
Morphine—UGT2B4—Metabolism—TYMS—colon cancer	3.41e-05	0.00169	CbGpPWpGaD
Morphine—OPRM1—TCR Signaling Pathway—AKT1—colon cancer	3.39e-05	0.00168	CbGpPWpGaD
Morphine—UGT1A1—NRF2 pathway—TGFB1—colon cancer	3.39e-05	0.00168	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—AXIN2—colon cancer	3.38e-05	0.00168	CbGpPWpGaD
Morphine—ABCB1—HIF-1-alpha transcription factor network—EP300—colon cancer	3.38e-05	0.00167	CbGpPWpGaD
Morphine—ABCB1—Allograft Rejection—CASP3—colon cancer	3.26e-05	0.00162	CbGpPWpGaD
Morphine—ABCB1—HIF-1-alpha transcription factor network—VEGFA—colon cancer	3.2e-05	0.00159	CbGpPWpGaD
Morphine—ABCB1—Integrated Pancreatic Cancer Pathway—TYMS—colon cancer	3.11e-05	0.00154	CbGpPWpGaD
Morphine—ABCB1—Integrated Pancreatic Cancer Pathway—BAX—colon cancer	3e-05	0.00149	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—AXIN2—colon cancer	2.86e-05	0.00142	CbGpPWpGaD
Morphine—ABCB1—Allograft Rejection—VEGFA—colon cancer	2.77e-05	0.00137	CbGpPWpGaD
Morphine—UGT1A8—Metabolism—PPARG—colon cancer	2.76e-05	0.00137	CbGpPWpGaD
Morphine—OPRL1—Signaling Pathways—FGFR3—colon cancer	2.61e-05	0.00129	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—ODC1—colon cancer	2.56e-05	0.00127	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—CHST5—colon cancer	2.56e-05	0.00127	CbGpPWpGaD
Morphine—ABCB1—Allograft Rejection—TGFB1—colon cancer	2.54e-05	0.00126	CbGpPWpGaD
Morphine—UGT2B4—Metabolism—PPARG—colon cancer	2.42e-05	0.0012	CbGpPWpGaD
Morphine—UGT2B15—Metabolism—PPARG—colon cancer	2.42e-05	0.0012	CbGpPWpGaD
Morphine—OPRL1—Signaling Pathways—APC—colon cancer	2.4e-05	0.00119	CbGpPWpGaD
Morphine—OPRL1—Signaling by GPCR—NRAS—colon cancer	2.4e-05	0.00119	CbGpPWpGaD
Morphine—ABCB1—Integrated Pancreatic Cancer Pathway—APC—colon cancer	2.29e-05	0.00113	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—CA7—colon cancer	2.27e-05	0.00113	CbGpPWpGaD
Morphine—OPRL1—Signaling Pathways—BRAF—colon cancer	2.25e-05	0.00112	CbGpPWpGaD
Morphine—ABCB1—Metabolism—ODC1—colon cancer	2.23e-05	0.00111	CbGpPWpGaD
Morphine—ABCB1—Metabolism—CHST5—colon cancer	2.23e-05	0.00111	CbGpPWpGaD
Morphine—OPRL1—Signaling by GPCR—EGFR—colon cancer	2.18e-05	0.00108	CbGpPWpGaD
Morphine—UGT1A8—Metabolism—PTGS2—colon cancer	2.17e-05	0.00108	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—ODC1—colon cancer	2.1e-05	0.00104	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—CHST5—colon cancer	2.1e-05	0.00104	CbGpPWpGaD
Morphine—OPRL1—GPCR downstream signaling—PIK3CA—colon cancer	2.09e-05	0.00103	CbGpPWpGaD
Morphine—OPRL1—Signaling by GPCR—KRAS—colon cancer	2.06e-05	0.00102	CbGpPWpGaD
Morphine—ABCB1—HIF-1-alpha transcription factor network—AKT1—colon cancer	2.04e-05	0.00101	CbGpPWpGaD
Morphine—UGT2B4—Metabolism—PTGS2—colon cancer	1.9e-05	0.000943	CbGpPWpGaD
Morphine—UGT2B15—Metabolism—PTGS2—colon cancer	1.9e-05	0.000943	CbGpPWpGaD
Morphine—OPRL1—Signaling by GPCR—PIK3CA—colon cancer	1.89e-05	0.000939	CbGpPWpGaD
Morphine—UGT1A3—Metabolism—ABCB1—colon cancer	1.86e-05	0.000923	CbGpPWpGaD
Morphine—UGT1A3—Metabolism—TYMS—colon cancer	1.83e-05	0.000906	CbGpPWpGaD
Morphine—UGT1A8—Metabolism—EP300—colon cancer	1.81e-05	0.000897	CbGpPWpGaD
Morphine—OPRL1—Signaling by GPCR—HRAS—colon cancer	1.75e-05	0.000869	CbGpPWpGaD
Morphine—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—colon cancer	1.74e-05	0.000861	CbGpPWpGaD
Morphine—OPRL1—GPCR downstream signaling—AKT1—colon cancer	1.7e-05	0.000845	CbGpPWpGaD
Morphine—OPRL1—Signaling Pathways—CASP3—colon cancer	1.69e-05	0.000837	CbGpPWpGaD
Morphine—OPRL1—Signaling Pathways—CCND1—colon cancer	1.64e-05	0.000815	CbGpPWpGaD
Morphine—OPRL1—Signaling Pathways—CTNNB1—colon cancer	1.63e-05	0.000807	CbGpPWpGaD
Morphine—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—colon cancer	1.61e-05	0.000799	CbGpPWpGaD
Morphine—OPRL1—Signaling Pathways—CDKN1A—colon cancer	1.59e-05	0.000788	CbGpPWpGaD
Morphine—UGT2B7—Metabolism—ABCB1—colon cancer	1.58e-05	0.000785	CbGpPWpGaD
Morphine—UGT2B4—Metabolism—EP300—colon cancer	1.58e-05	0.000784	CbGpPWpGaD
Morphine—UGT2B15—Metabolism—EP300—colon cancer	1.58e-05	0.000784	CbGpPWpGaD
Morphine—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—colon cancer	1.57e-05	0.000778	CbGpPWpGaD
Morphine—UGT2B7—Metabolism—TYMS—colon cancer	1.55e-05	0.000771	CbGpPWpGaD
Morphine—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—colon cancer	1.55e-05	0.00077	CbGpPWpGaD
Morphine—OPRL1—Signaling by GPCR—AKT1—colon cancer	1.55e-05	0.000767	CbGpPWpGaD
Morphine—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—colon cancer	1.52e-05	0.000752	CbGpPWpGaD
Morphine—OPRL1—Signaling Pathways—EP300—colon cancer	1.51e-05	0.00075	CbGpPWpGaD
Morphine—OPRL1—Signaling Pathways—SRC—colon cancer	1.47e-05	0.000729	CbGpPWpGaD
Morphine—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—colon cancer	1.44e-05	0.000716	CbGpPWpGaD
Morphine—OPRL1—Signaling Pathways—VEGFA—colon cancer	1.43e-05	0.00071	CbGpPWpGaD
Morphine—OPRL1—Signaling Pathways—NRAS—colon cancer	1.41e-05	0.000702	CbGpPWpGaD
Morphine—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—colon cancer	1.4e-05	0.000696	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—CHST5—colon cancer	1.37e-05	0.000682	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—ODC1—colon cancer	1.37e-05	0.000682	CbGpPWpGaD
Morphine—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—colon cancer	1.37e-05	0.000678	CbGpPWpGaD
Morphine—UGT1A8—Metabolism—PIK3CA—colon cancer	1.34e-05	0.000664	CbGpPWpGaD
Morphine—OPRL1—Signaling Pathways—MYC—colon cancer	1.32e-05	0.000654	CbGpPWpGaD
Morphine—OPRL1—Signaling Pathways—TGFB1—colon cancer	1.31e-05	0.000652	CbGpPWpGaD
Morphine—UGT1A3—Metabolism—PPARG—colon cancer	1.29e-05	0.000642	CbGpPWpGaD
Morphine—OPRL1—Signaling Pathways—EGFR—colon cancer	1.29e-05	0.000639	CbGpPWpGaD
Morphine—UGT1A1—Metabolism—ABCB1—colon cancer	1.29e-05	0.000638	CbGpPWpGaD
Morphine—UGT1A1—Metabolism—TYMS—colon cancer	1.26e-05	0.000626	CbGpPWpGaD
Morphine—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—colon cancer	1.26e-05	0.000624	CbGpPWpGaD
Morphine—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—colon cancer	1.25e-05	0.000622	CbGpPWpGaD
Morphine—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—colon cancer	1.23e-05	0.00061	CbGpPWpGaD
Morphine—OPRL1—Signaling Pathways—KRAS—colon cancer	1.22e-05	0.000604	CbGpPWpGaD
Morphine—UGT2B4—Metabolism—PIK3CA—colon cancer	1.17e-05	0.00058	CbGpPWpGaD
Morphine—UGT2B15—Metabolism—PIK3CA—colon cancer	1.17e-05	0.00058	CbGpPWpGaD
Morphine—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—colon cancer	1.16e-05	0.000576	CbGpPWpGaD
Morphine—OPRL1—Signaling Pathways—PIK3CA—colon cancer	1.12e-05	0.000555	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—FGFR3—colon cancer	1.11e-05	0.000552	CbGpPWpGaD
Morphine—UGT2B7—Metabolism—PPARG—colon cancer	1.1e-05	0.000546	CbGpPWpGaD
Morphine—UGT1A8—Metabolism—AKT1—colon cancer	1.09e-05	0.000542	CbGpPWpGaD
Morphine—OPRL1—Signaling Pathways—TP53—colon cancer	1.08e-05	0.000537	CbGpPWpGaD
Morphine—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—colon cancer	1.07e-05	0.00053	CbGpPWpGaD
Morphine—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—colon cancer	1.06e-05	0.000524	CbGpPWpGaD
Morphine—OPRL1—Signaling Pathways—HRAS—colon cancer	1.04e-05	0.000513	CbGpPWpGaD
Morphine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—colon cancer	1.03e-05	0.000512	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—APC—colon cancer	1.02e-05	0.000507	CbGpPWpGaD
Morphine—OPRD1—Signaling by GPCR—NRAS—colon cancer	1.02e-05	0.000507	CbGpPWpGaD
Morphine—UGT1A3—Metabolism—PTGS2—colon cancer	1.02e-05	0.000505	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—FGFR3—colon cancer	9.76e-06	0.000484	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—BRAF—colon cancer	9.61e-06	0.000477	CbGpPWpGaD
Morphine—UGT2B4—Metabolism—AKT1—colon cancer	9.55e-06	0.000474	CbGpPWpGaD
Morphine—UGT2B15—Metabolism—AKT1—colon cancer	9.55e-06	0.000474	CbGpPWpGaD
Morphine—OPRD1—Signaling by GPCR—EGFR—colon cancer	9.31e-06	0.000462	CbGpPWpGaD
Morphine—OPRL1—Signaling Pathways—AKT1—colon cancer	9.14e-06	0.000453	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—APC—colon cancer	8.97e-06	0.000445	CbGpPWpGaD
Morphine—OPRK1—Signaling by GPCR—NRAS—colon cancer	8.97e-06	0.000445	CbGpPWpGaD
Morphine—UGT1A1—Metabolism—PPARG—colon cancer	8.94e-06	0.000444	CbGpPWpGaD
Morphine—OPRD1—GPCR downstream signaling—PIK3CA—colon cancer	8.9e-06	0.000442	CbGpPWpGaD
Morphine—OPRD1—Signaling by GPCR—KRAS—colon cancer	8.8e-06	0.000436	CbGpPWpGaD
Morphine—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—colon cancer	8.72e-06	0.000433	CbGpPWpGaD
Morphine—UGT2B7—Metabolism—PTGS2—colon cancer	8.66e-06	0.000429	CbGpPWpGaD
Morphine—UGT1A3—Metabolism—EP300—colon cancer	8.47e-06	0.00042	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—BRAF—colon cancer	8.43e-06	0.000418	CbGpPWpGaD
Morphine—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	8.32e-06	0.000413	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—FGFR3—colon cancer	8.25e-06	0.000409	CbGpPWpGaD
Morphine—OPRK1—Signaling by GPCR—EGFR—colon cancer	8.17e-06	0.000405	CbGpPWpGaD
Morphine—OPRD1—Signaling by GPCR—PIK3CA—colon cancer	8.08e-06	0.000401	CbGpPWpGaD
Morphine—OPRK1—GPCR downstream signaling—PIK3CA—colon cancer	7.81e-06	0.000387	CbGpPWpGaD
Morphine—OPRK1—Signaling by GPCR—KRAS—colon cancer	7.72e-06	0.000383	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—APC—colon cancer	7.58e-06	0.000376	CbGpPWpGaD
Morphine—OPRM1—Signaling by GPCR—NRAS—colon cancer	7.58e-06	0.000376	CbGpPWpGaD
Morphine—OPRD1—Signaling by GPCR—HRAS—colon cancer	7.48e-06	0.000371	CbGpPWpGaD
Morphine—OPRD1—GPCR downstream signaling—AKT1—colon cancer	7.27e-06	0.000361	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—CASP3—colon cancer	7.21e-06	0.000357	CbGpPWpGaD
Morphine—UGT2B7—Metabolism—EP300—colon cancer	7.2e-06	0.000357	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—BRAF—colon cancer	7.12e-06	0.000353	CbGpPWpGaD
Morphine—OPRK1—Signaling by GPCR—PIK3CA—colon cancer	7.09e-06	0.000352	CbGpPWpGaD
Morphine—UGT1A1—Metabolism—PTGS2—colon cancer	7.04e-06	0.000349	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—CCND1—colon cancer	7.01e-06	0.000348	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—CTNNB1—colon cancer	6.95e-06	0.000344	CbGpPWpGaD
Morphine—CYP2C8—Metabolism of lipids and lipoproteins—EP300—colon cancer	6.92e-06	0.000343	CbGpPWpGaD
Morphine—OPRM1—Signaling by GPCR—EGFR—colon cancer	6.9e-06	0.000342	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—CDKN1A—colon cancer	6.79e-06	0.000336	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—ABCB1—colon cancer	6.77e-06	0.000336	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—TYMS—colon cancer	6.65e-06	0.00033	CbGpPWpGaD
Morphine—OPRD1—Signaling by GPCR—AKT1—colon cancer	6.6e-06	0.000328	CbGpPWpGaD
Morphine—OPRM1—GPCR downstream signaling—PIK3CA—colon cancer	6.6e-06	0.000327	CbGpPWpGaD
Morphine—OPRK1—Signaling by GPCR—HRAS—colon cancer	6.56e-06	0.000325	CbGpPWpGaD
Morphine—OPRM1—Signaling by GPCR—KRAS—colon cancer	6.52e-06	0.000323	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—EP300—colon cancer	6.46e-06	0.00032	CbGpPWpGaD
Morphine—OPRK1—GPCR downstream signaling—AKT1—colon cancer	6.38e-06	0.000316	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—CASP3—colon cancer	6.32e-06	0.000313	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—SRC—colon cancer	6.28e-06	0.000311	CbGpPWpGaD
Morphine—UGT1A3—Metabolism—PIK3CA—colon cancer	6.26e-06	0.000311	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—CCND1—colon cancer	6.15e-06	0.000305	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—VEGFA—colon cancer	6.11e-06	0.000303	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—CTNNB1—colon cancer	6.09e-06	0.000302	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—NRAS—colon cancer	6.04e-06	0.0003	CbGpPWpGaD
Morphine—OPRM1—Signaling by GPCR—PIK3CA—colon cancer	5.99e-06	0.000297	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—CDKN1A—colon cancer	5.95e-06	0.000295	CbGpPWpGaD
Morphine—UGT1A1—Metabolism—EP300—colon cancer	5.85e-06	0.00029	CbGpPWpGaD
Morphine—ABCB1—Metabolism—TYMS—colon cancer	5.79e-06	0.000287	CbGpPWpGaD
Morphine—OPRK1—Signaling by GPCR—AKT1—colon cancer	5.79e-06	0.000287	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—EP300—colon cancer	5.66e-06	0.000281	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—MYC—colon cancer	5.63e-06	0.000279	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—TGFB1—colon cancer	5.61e-06	0.000278	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—ABCB1—colon cancer	5.56e-06	0.000276	CbGpPWpGaD
Morphine—OPRM1—Signaling by GPCR—HRAS—colon cancer	5.54e-06	0.000275	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—SRC—colon cancer	5.51e-06	0.000273	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—EGFR—colon cancer	5.5e-06	0.000273	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—TYMS—colon cancer	5.46e-06	0.000271	CbGpPWpGaD
Morphine—OPRM1—GPCR downstream signaling—AKT1—colon cancer	5.39e-06	0.000267	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—VEGFA—colon cancer	5.36e-06	0.000266	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—CASP3—colon cancer	5.34e-06	0.000265	CbGpPWpGaD
Morphine—UGT2B7—Metabolism—PIK3CA—colon cancer	5.33e-06	0.000264	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—NRAS—colon cancer	5.3e-06	0.000263	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—KRAS—colon cancer	5.2e-06	0.000258	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—CCND1—colon cancer	5.2e-06	0.000258	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—CTNNB1—colon cancer	5.15e-06	0.000255	CbGpPWpGaD
Morphine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	5.12e-06	0.000254	CbGpPWpGaD
Morphine—UGT1A3—Metabolism—AKT1—colon cancer	5.12e-06	0.000254	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—CDKN1A—colon cancer	5.03e-06	0.000249	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—MYC—colon cancer	4.93e-06	0.000245	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—TGFB1—colon cancer	4.92e-06	0.000244	CbGpPWpGaD
Morphine—OPRM1—Signaling by GPCR—AKT1—colon cancer	4.89e-06	0.000243	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—EGFR—colon cancer	4.83e-06	0.000239	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—EP300—colon cancer	4.78e-06	0.000237	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—PIK3CA—colon cancer	4.78e-06	0.000237	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—PPARG—colon cancer	4.71e-06	0.000234	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—SRC—colon cancer	4.65e-06	0.000231	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—TP53—colon cancer	4.62e-06	0.000229	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—KRAS—colon cancer	4.56e-06	0.000226	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—VEGFA—colon cancer	4.53e-06	0.000225	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—NRAS—colon cancer	4.48e-06	0.000222	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—HRAS—colon cancer	4.42e-06	0.000219	CbGpPWpGaD
Morphine—UGT2B7—Metabolism—AKT1—colon cancer	4.35e-06	0.000216	CbGpPWpGaD
Morphine—UGT1A1—Metabolism—PIK3CA—colon cancer	4.33e-06	0.000215	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—PIK3CA—colon cancer	4.19e-06	0.000208	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—MYC—colon cancer	4.17e-06	0.000207	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—TGFB1—colon cancer	4.16e-06	0.000206	CbGpPWpGaD
Morphine—ABCB1—Metabolism—PPARG—colon cancer	4.1e-06	0.000203	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—EGFR—colon cancer	4.08e-06	0.000202	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—TP53—colon cancer	4.05e-06	0.000201	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—AKT1—colon cancer	3.9e-06	0.000193	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—HRAS—colon cancer	3.87e-06	0.000192	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—PPARG—colon cancer	3.87e-06	0.000192	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—KRAS—colon cancer	3.85e-06	0.000191	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—PTGS2—colon cancer	3.7e-06	0.000184	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—ABCB1—colon cancer	3.63e-06	0.00018	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—TYMS—colon cancer	3.57e-06	0.000177	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—PIK3CA—colon cancer	3.54e-06	0.000176	CbGpPWpGaD
Morphine—UGT1A1—Metabolism—AKT1—colon cancer	3.54e-06	0.000175	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—TP53—colon cancer	3.42e-06	0.00017	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—AKT1—colon cancer	3.42e-06	0.00017	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—HRAS—colon cancer	3.27e-06	0.000162	CbGpPWpGaD
Morphine—ABCB1—Metabolism—PTGS2—colon cancer	3.23e-06	0.00016	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—EP300—colon cancer	3.08e-06	0.000153	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—PTGS2—colon cancer	3.04e-06	0.000151	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—AKT1—colon cancer	2.89e-06	0.000143	CbGpPWpGaD
Morphine—ABCB1—Metabolism—EP300—colon cancer	2.68e-06	0.000133	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—EP300—colon cancer	2.53e-06	0.000125	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—PPARG—colon cancer	2.53e-06	0.000125	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—PIK3CA—colon cancer	2.28e-06	0.000113	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—PTGS2—colon cancer	1.99e-06	9.86e-05	CbGpPWpGaD
Morphine—ABCB1—Metabolism—PIK3CA—colon cancer	1.99e-06	9.85e-05	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—PIK3CA—colon cancer	1.87e-06	9.28e-05	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—AKT1—colon cancer	1.86e-06	9.23e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—EP300—colon cancer	1.65e-06	8.2e-05	CbGpPWpGaD
Morphine—ABCB1—Metabolism—AKT1—colon cancer	1.62e-06	8.04e-05	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—AKT1—colon cancer	1.53e-06	7.58e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—PIK3CA—colon cancer	1.22e-06	6.07e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—AKT1—colon cancer	9.99e-07	4.96e-05	CbGpPWpGaD
